Clinical trial Recruiting at 3 sites Observational Ages 18 and up Women only

Research on herbicide exposure effects during pregnancy

Official title: Children's Health in the Heartland Study

Run by Heartland Health Research Alliance · NCT05492708 · Data updated 2026-11-12

This study is trying to see how exposure to herbicides during pregnancy affects the health of mothers and their babies.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment2600 (estimated)
SponsorHeartland Health Research Alliance
Academic / other
Locations4 sites (Indianapolis, Indiana and 3 other locations)
StatusRecruiting
StartedJanuary 11, 2020
Main results expectedJanuary 2027
Study endsJanuary 2029
Registry record updatedJune 29, 2025
Trial IDNCT05492708 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant individuals aged 18 or older who are less than or equal to 20 weeks pregnant and reside in one of the 13 Heartland Study region states.

Probably not a fit

Patients who are not fluent in English or unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Heartland Study is a prospective, observational study enrolling up to 2,600 pregnant individuals across the Heartland States in the U.S. It aims to investigate the health effects of herbicides on maternal and infant health by measuring biomarkers of herbicide exposure and evaluating their associations with pregnancy outcomes. Participants will provide urine and buccal samples, and data will be collected through questionnaires regarding various environmental and lifestyle factors. The study will follow participants from early pregnancy through childbirth to assess potential impacts on fetal health and child development.

Why it matters

Potential benefit: If successful, this study could provide critical insights into the effects of herbicide exposure on pregnancy outcomes, potentially leading to improved health guidelines for pregnant individuals.

How similar studies have gone: Other studies have shown success in evaluating environmental exposures and their effects on pregnancy outcomes, making this approach both relevant and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant persons ages 18 or older at time of consent who are ≤20+6 weeks pregnant. Best clinical estimate of gestational age will be utilized for recruitment purposes. Enrollment in the first trimester (≤ 13 + 6) is preferred, but anyone ≤ 20 +6 is permitted.
* Living in one of the 13 Heartland Study region states at the time of enrollment (Arkansas, Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, or Wisconsin) Optional inclusion of the putative biological father

Exclusion Criteria:

* Participants who are not fluent in and/or do not fully understand, read, write, or speak the English language.
* Other inability to provide informed consent to participate

Where it's running

  • Indiana University Medical Center
    Indianapolis, Indiana, United States
    Recruiting
  • University of Iowa Health Care
    Iowa City, Iowa, United States
    Recruiting
  • Marshfield Clinic
    Marshfield, Wisconsin, United States
    Recruiting
  • Gundersen Health
    La Crosse, Wisconsin, United States
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.